跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,469 条关于
“Meiji Seika Pharma Co. Ltd.”
全部
26,469
临床试验
8,292
药物
2,783
机构
5,272
资讯
10,122
9个月前
Meiji Seika Pharma Partners with MBC BioLabs to Accelerate Drug Discovery Innovation
6个月前
Meiji Seika Pharma Launches Phase I Trial of ME3241, Novel PD-1 Agonist for Autoimmune Diseases
去年
Osivax Raises €10M in Series B Funding to Advance Broad-Spectrum Influenza Vaccine Development
2年前
Spero Therapeutics Initiates Phase 3 Trial for First Oral Carbapenem in US, Targeting Complicated UTIs
9个月前
Lyric Bio Raises $6.6M to Revolutionize IVIg Production with Ultra-High-Density Bioreactors
去年
Newron Pharmaceuticals Expands Evenamide Reach in Asia with New Licensing Agreements
去年
Arcturus Therapeutics Advances mRNA Pipeline and Reports Q3 2024 Financial Results
去年
Eisai Advances LEQEMBI Subcutaneous and IV Maintenance Dosing Applications for Alzheimer's Disease
去年
AIM Vaccine Submits 13-Valent Pneumonia Conjugate Vaccine for Approval After Positive Phase III Results
2年前
Japan Approves CSL and Arcturus Therapeutics' Updated sa-mRNA COVID-19 Vaccine Targeting JN.1 Variant
第 1 页，共 1013 页
上一页
下一页
